meprobamate

Generic: meprobamate

Labeler: cipla usa inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name meprobamate
Generic Name meprobamate
Labeler cipla usa inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

meprobamate 200 mg/1

Manufacturer
Cipla USA Inc.

Identifiers & Regulatory

Product NDC 69097-974
Product ID 69097-974_1fe09b66-c58f-4d50-8932-96f52bda4bcb
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA040797
DEA Schedule civ
Listing Expiration 2026-12-31
Marketing Start 2021-06-07

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 69097974
Hyphenated Format 69097-974

Supplemental Identifiers

RxCUI
197928 197929
UNII
9I7LNY769Q

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name meprobamate (source: ndc)
Generic Name meprobamate (source: ndc)
Application Number ANDA040797 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 200 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE (69097-974-07)
source: ndc

Packages (1)

69097-974-07 100 TABLET in 1 BOTTLE (69097-974-07)

Ingredients (1)

meprobamate (200 mg/1)

Linked Drug Pages (1)

Meprobamate ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "1fe09b66-c58f-4d50-8932-96f52bda4bcb", "openfda": {"unii": ["9I7LNY769Q"], "rxcui": ["197928", "197929"], "spl_set_id": ["17d814e2-b277-4dce-8615-e7fd7cab773f"], "manufacturer_name": ["Cipla USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (69097-974-07)", "package_ndc": "69097-974-07", "marketing_start_date": "20210607"}], "brand_name": "Meprobamate", "product_id": "69097-974_1fe09b66-c58f-4d50-8932-96f52bda4bcb", "dosage_form": "TABLET", "product_ndc": "69097-974", "dea_schedule": "CIV", "generic_name": "Meprobamate", "labeler_name": "Cipla USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Meprobamate", "active_ingredients": [{"name": "MEPROBAMATE", "strength": "200 mg/1"}], "application_number": "ANDA040797", "marketing_category": "ANDA", "marketing_start_date": "20210607", "listing_expiration_date": "20261231"}